Two-year cost-effectiveness of different COBRA-like intensive remission induction schemes in early rheumatoid arthritis: a piggyback study on the pragmatic randomised controlled CareRA trial.
Sofia PazminoAnnelies BoonenVeerle StoutenDiederik De CockJohan JolyKristien Van der ElstRene WesthovensPatrick VerschuerenPublished in: Annals of the rheumatic diseases (2020)
NCT01172639.